Development of a Highly Sensitive and Rapid Lateral Flow Immunochromatographic Assay for the Quantitative Detection of Small Extracellular Vesicles

Inside every drop of blood, urine, and saliva, tiny bubbles float, carrying messages from the cells that released them. These are extracellular vesicles, microscopic packages wrapped in a membrane that cells use to talk to one another. Among them, the smallest versions, known as small extracellular vesicles, are particularly important. They are now recognized as vital messengers that can reveal the health of their parent cells, including whether a tumor is growing. Because they circulate freely in the body, doctors are eager to use them as a way to diagnose diseases like cancer without needing invasive surgery. However, finding and counting these tiny bubbles is notoriously difficult. They are small, they are mixed in with a sea of other proteins, and the tools currently used to study them are often slow, expensive, and require complex laboratory equipment.

A team of researchers has developed a new way to catch and count these vesicles that is faster, cheaper, and far more sensitive than previous methods. They created a specialized test strip, similar to a home pregnancy test, but engineered to detect a specific marker on the surface of these vesicles. By changing the order in which the sample and detection tools are applied, and by using a light-emitting chemical reaction instead of a simple color change, they built a system capable of spotting extremely low numbers of vesicles. This advancement brings the possibility of rapid, routine blood tests for early disease detection much closer to reality.

The researchers focused on a specific protein called CD9, which sits on the surface of these small vesicles like a flag. To find them, they designed a lateral flow immunochromatographic assay, a device where a liquid sample travels along a strip of porous material. As the liquid moves, it encounters antibodies that are designed to grab onto the CD9 protein. In a traditional setup, the sample and the detection antibodies are mixed together in a cup before being poured onto the strip. The team tested this standard approach against a new, two-step method. In the new method, the sample is poured onto the strip first, allowing the vesicles to settle and attach to the strip on their own. Only after they are securely in place are the detection antibodies added.

This change in procedure solved a major physical problem. When the sample and detection antibodies are mixed together beforehand, the antibodies can crowd around the vesicle and cover up the very spots they are supposed to find. This is like trying to stick a label on a ball that is already covered in other labels; the new label cannot find a clear spot to attach. By letting the vesicles attach to the strip first, the researchers ensured they were exposed and ready. When the detection antibodies were added later, they could bind freely and strongly. This simple shift in timing resulted in a signal that was significantly stronger, proving that the order of operations matters deeply when dealing with objects this small.

To make the test even more sensitive, the team replaced the standard gold particles that usually create a visible red line with a system that produces light. In the standard version, gold particles cluster together to form a colored line that the human eye can see. While this works for larger amounts of the target, it struggles when the amount is very small. The researchers instead used antibodies linked to enzymes that trigger a chemical reaction, causing the test line to glow in the dark. This light-based detection is far more powerful. It allowed the device to detect as few as one hundred thousand particles, a level of sensitivity that is forty to sixty times better than the color-based method. This threshold is critical because it matches the low concentrations of disease markers found in the blood of patients with early-stage cancer.

The study also revealed that different tools are best for different jobs. While the light-based system is excellent for finding trace amounts of a target, the traditional gold particle method offers a wider range for measuring large quantities. The gold-based test remained accurate and linear even when the number of particles was very high, whereas the light-based system could become saturated and lose accuracy if too many particles were present. This means the new platform is versatile: it can be configured to hunt for rare, early signs of disease with extreme sensitivity, or to measure high levels of markers in patients with advanced conditions.

By combining a smarter way of loading the sample with a more sensitive way of reading the result, the researchers have created a dual-purpose tool. It is simple enough to be used outside of a high-tech lab, requiring no bulky machinery, yet sensitive enough to meet the demands of clinical diagnostics. This work demonstrates that by carefully understanding the physical interactions between molecules and the mechanics of the test strip, scientists can overcome the limitations of older methods. The result is a practical framework that could soon make the routine monitoring of these tiny biological messengers a standard part of medical care.